Delivery Order SPE2DR25D3102-SPE2DR26F2Q2V
- Not listed
- The Defense Logistics Agency awarded a $1,117.74 delivery order to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 ml vials (5 ml quantity) on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order is non-set-aside and represents a competitively awarded transaction under the company's existing contract vehicles with DLA. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $7,415.12 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,259.53 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Dexamethasone 4 mg/mL vials. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,778.44 to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Dexamethasone 20 mg/5 mL vials (5 mL quantity). This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,285.33 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,262,613 units of the pharmaceutical product Dexamethasone 4 mg Tablet, 100s. This contract has a firm fixed price and an ultimate completion date of July 29, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of dexamethasone 20 mg/5 ml vials. The $2,997.21 order is to be completed by January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide pharmaceutical products and medical supplies to DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $5,563.00 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/ml vials, with an ultimate completion date of December 19, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for a critical corticosteroid medication used across military and federal healthcare systems. The contract will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,707.89 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/mL in vial form, with an ultimate completion date of November 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,069.28 to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 ml vials on December 16, 2025, with completion scheduled for December 17, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply vehicle running through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.64 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials on a firm fixed price basis. The contract, awarded December 8, 2025, with completion targeted for December 9, 2025, represents a routine pharmaceutical procurement supporting federal medical supply chain operations. This award carries no set-aside designation, indicating it was competitively awarded through open competition. The place of...
- SPE2DR25D3102Indefinite Delivery Contract
- SPE2DR25D3102-SPE2DR26F2Q2VDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,634.35 to Amerisourcebergen Drug Corp for the supply of Dexamethasone 6 mg tablets (100 count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price, non-set-aside contract was performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a task order executed under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company's IDC with DLA encompasses a broad spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The competitive award of this delivery order demonstrates the contractor's capability to efficiently fulfill essential pharmaceutical requirements for federal medical institutions through the existing prime vendor contract structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 1/8/26 |